Optimal timing of resumption of warfarin after intracranial hemorrhage

Stroke

Volumn 41, Issue 12, 2010, Pages 2860-2866

  Majeed, Ammar ^a,b   Kim, Yang Ki ^c,e   Roberts, Robin S ^d,f   Holmström, Margareta ^a   Schulman, Sam ^a,e,f  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Malar Hospital   (Sweden)

^c Soonchunhyang University   (South Korea)

^d Department of Clinical Epidemiology and Biostatistics ^*  (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

anticoagulation; intracranial hemorrhage; ischemic stroke; management

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE; TIME FACTORS; WARFARIN;

EID: 78650416405     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.593087     Document Type: Article

References (18)

1. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:257S-298S. (Pubitemid 351892969)
2. Salem DN, O'Gara PT, Madias C, Pauker SG. Valvular and structural heart disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:593S- 629S.
3. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation. JAMA. 2001;285: 2864-2870.
4. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:454S-545S. (Pubitemid 351892971)
5. Ananthasubramaniam K, Beattie JN, Rosman HS, Jayam V, Borzak S. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest. 2001;119:478-484.
6. Babikian VL, Kase CS, Pessin MS, Caplan LR, Gorelick PB. Resumption of anticoagulation after intracranial bleeding in patients with prosthetic heart valves. Stroke. 1988;19:407-408.
7. Bertram M, Bonsanto M, Hacke W, Schwab S. Managing the therapeutic dilemma: Patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol. 2000;247:209-214.
8. Butler AC, Tait RC. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: A 2-year follow-up. Br J Haematol. 1998;103:1064-1066.
9. Claassen DO, Kazemi N, Zubkov AY, Wijdicks EF, Rabinstein AA. Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol. 2008;65:1313-1318.
10. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagu-lation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol. 2000;57:1710-1713.
11. Punthakee X, Doobay J, Anand SS. Oral-anticoagulant-related intracere-bral hemorrhage. Thromb Res. 2002;108:31-36.
12. Wijdicks EF, Schievink WI, Brown RD, Mullany CJ. The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurg. 1998;42:769-773.
13. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the american heart association/ american stroke association stroke council, high blood pressure research council, and the quality of care and outcomes in research interdisciplinary working group. Circ. 2007;116:e391-e413.
14. Romualdi E, Micieli E, Ageno W, Squizzato A. Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review. Thromb Haemost. 2009;101:290-297.
15. Aguilar MI, Hart RG, Kase CS, Freeman WD, Hoeben BJ, Garcia RC, Ansell JE, Mayer SA, Norrving B, Rosand J, Steiner T, Wijdicks EF, Yamaguchi T, Yasaka M. Treatment of warfarin-associated intracerebral hemorrhage: Literature review and expert opinion. Mayo Clin Proc. 2007;82:82-92.
16. Van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA. 2002;288:2441-2448.
17. Hawryluk GW, Austin JW, Furlan JC, Lee JB, O'Kelly C, Fehlings MG. Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost. 2010;8:1500-1508.
18. Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke. 2003;34:1710-1716.